We hypothesise that severe systemic inflammatory response, cytokine storm and metabolic disorders triggered by AP may inhibit CLIC5 expression and interfere with the proliferation of extracellular matrix through pro‐inflammatory factors, which in turn exacerbate muscle protein degradation and regeneration disorders, and ultimately promote the progression of sarcopenia. The gene discussed is CLIC5; the disease is Other metabolic disease.